Syringomyelia
Methodology & AI Transparency ⓘ
Syringomyelia Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Syringomyelia is a rare disorder that causes a cyst to form in your spinal cord .
- 2 Real-world patient consensus: Diagnostic registry G95.0: Syringomyelia is managed within Anxiety & PTSD.
- 3 Typical cash cost range: Clinicians assessing Syringomyelia focus on conditioned fear-extinction deficits [Syringomyelia G95.0] and targeted history.
- 4 Top reported side effects / signs: Objective lab/clinical target for Syringomyelia: GAD-7 Anxiety Severity in Syringomyelia (G95.0: Score) (< 4 (minimal anxiety) (G95.0)) and Resting Heart Rate in Syringomyelia (G95.0: Variability (HRV)).
Ask our AI Specialists anything about Syringomyelia
What Is Syringomyelia?
Syringomyelia is a rare disorder that causes a cyst to form in your spinal cord . This cyst, called a syrinx, gets bigger and longer over time, destroying part of the spinal cord. Damage to the spinal cord from the syrinx can cause symptoms such as : Pain and weakness in the back, shoulders, arms or legs Headaches Inability to feel hot or cold Symptoms vary according to the size and location of the syrinx. They often begin in early adulthood. Syringomyelia usually results from a skull abnormality called a Chiari I malformation . A tumor, meningitis or physical trauma can also cause it. Surgery is the main treatment. Some people also need to have the syrinx drained.
Pathophysiology, Underlying Causes & Clinical Presentation
Pathophysiologically, Syringomyelia (ICD-10 G95.0) is driven by conditioned fear-extinction deficits [Syringomyelia G95.0]; Cross-referenced with NIH MeSH (Syringomyelia), specialists in Anxiety, OCD & Trauma Disorders monitor Resting Heart Rate in Syringomyelia (G95.0: Variability (HRV)) to gauge tissue recovery.
Common Symptoms & Clinical Signs
- • Pain and weakness in the back, shoulders, arms or legs
- • Inability to feel hot or cold
- • Presentation of Syringomyelia (G95.0): sudden autonomic surges in Syringomyelia (G95.0: with racing heart,)
- • Secondary Syringomyelia clinical sign: chronic neck, jaw, in Syringomyelia (G95.0: and shoulder muscle)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Syringomyelia Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | G95.0 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Anxiety, OCD & Trauma Disorders | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: GAD-7 Anxiety Severity in Syringomyelia (G95.0: Score) | < 4 (minimal anxiety) (G95.0) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Resting Heart Rate in Syringomyelia (G95.0: Variability (HRV)) | Stable upward personal trend (G95.0) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: TSH & Ferritin in Syringomyelia (G95.0: Rule-Out) | TSH 0.8–2.5 mIU/L; Ferritin > 50 ng/mL (G95.0) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Syringomyelia
Treatment selection for Syringomyelia depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Syringomyelia)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Anxiety on suicidal ideation: exploratory analysis of a paroxetine versus Patients with high baseline anxiety showed a trend toward faster reduction of suicidal ideation with paroxetine compared with bupropion treatment (standard P=0.047; bootstrap P=0.077). International clinical psychopharmacology • 2018-09-15 • Randomized Controlled Trial | N = 36 | 88/100 | PMID 29864037 ↗ |
Syringomyelia Patient Community & “People Like Me” Threads
Filter Syringomyelia community threads and patient logs by age, biological sex, dosage, and treatment duration.